Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low Dose of Interleukin-2 Following Allogeneic Unmanipulated Blood and Marrow Transplantation in Treating Patients With Standard Risk Hematologic Malignancy

NCT01517347 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT01517347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01517347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low Dose of Interleukin-2 Following Allogeneic Unmanipulated Blood and Marrow Transplantation in Treating Patients With Standard Risk Hematologic Malignancy
Lead sponsor
Peking University People's Hospital
Phase
Not applicable
Overall status
Terminated
Start date
January 31, 2012
Completion date
August 31, 2015
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia